Company Pays $158,760 to Resolve Claims Related to Controlled Substance Thefts From Pharmacies During Inventory
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • Company Pays $158,760 to Resolve Claims Related to Controlled Substance Thefts From Pharmacies During Inventory

Company Pays $158,760 to Resolve Claims Related to Controlled Substance Thefts From Pharmacies During Inventory

Septiembre 30, 2022
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kenneth M. Heino
Phone Number: 862-373-3557

RGIS LLC Terminated Employee for Stealing Vicodin – Later Rehired Same Employee Who Stole Oxycodone

ALBANY, NEW YORK –  RGIS LLC (RGIS) and its affiliated company, Retail Services WIS Corporation (WIS), agreed to pay $158,760 to resolve allegations that they caused violations of the Controlled Substances Act.  RGIS and WIS employees were implicated in the theft of controlled substances from pharmacies in upstate New York and throughout the United States.  As part of the settlement, RGIS and WIS are changing their policies to require more thorough vetting of employees assigned to inventory pharmacies nationwide. 

The announcement was made by Carla B. Freedman, the United States Attorney for the Northern District of New York and Frank A. Tarentino III, Special Agent in Charge of the U.S. Drug Enforcement Administration (DEA), New York Division.

“This settlement strengthens policies that previously provided opportunities for employees to steal while they inventoried controlled substances,” said United States Attorney Freedman. “We are committed to working with our DEA partners to eliminate sources of drug diversion in our communities.”  

“Diversion prevention programs and the Controlled Substance Act are in place to safeguard the public from the perils of drug use and misuse,” said DEA Special Agent in Charge Frank Tarentino.  “This is an example of the many investigative capabilities at DEA’s disposal to combat drug overdoses and poisonings, and I applaud our law enforcement partners, especially the U.S. Attorney’s Office Northern District of New York for their partnership and diligent efforts.”

RGIS and WIS provide inventory services to client-retail stores throughout the United States, including retail pharmacies.  According to RGIS and WIS policies, only handpicked, high-caliber, well-respected employees are assigned to pharmacy inventory teams and they are required to undergo a drug test and criminal background check.  RGIS and WIS maintain a “zero tolerance policy” for theft. 

Despite these policies, RGIS and WIS employees were implicated in stealing controlled substances from several pharmacies.  For example, in July 2017, an RGIS employee stole Vicodin pills while inventorying a retail pharmacy in Schenectady, New York.  RGIS terminated the employee but later rehired him.  In 2020, that same employee was implicated in stealing narcotics from three pharmacies in Fort Edward, Saratoga, and Glens Falls, New York.  RGIS employees were also implicated in stealing narcotics from pharmacies in Kentucky, North Carolina, and Louisiana.  In addition, WIS employees were implicated in stealing narcotics from pharmacies in Dallas, Duncanville, and Little Elm, Texas. 

RGIS and WIS agreed to implement additional procedures to ensure the proper vetting of employees assigned to inventory pharmacies, and to make the results of the vetting available to their pharmacy-clients.  The pharmacy-clients, as DEA registrants, are ultimately responsible for supervising all personnel on the premises and preventing the diversion of controlled substances.   

DEA’s Albany Diversion Group led this investigation with assistance from the Tactical Diversion Squads in Albany, New York; Dallas, Texas; and Charleston, West Virginia.  The New York State Police, Glens Falls Police Department, and the Little Elm (Texas) Police Department also provided assistance. 

Assistant U.S. Attorney Christopher R. Moran represented the United States in this matter

 

###

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Frank A. Tarentino III Special Agent in Charge - New York
@DEANewYorkDiv
  • Facebook
  • X
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster